Call 1.800.4HUMIRA for resources designed with you in mind—at no additional cost.

  • Tools to help you get started and stay on
    track with your HUMIRA treatment
  • Ways to help you save on HUMIRA
  • Personalized support as you learn how to take HUMIRA

Be sure to visit again soon for more information, including:

  • Treating non-infectious uveitis with HUMIRA
  • How to find a uveitis-treating specialist with our physician locator tool
  • Understanding how HUMIRA works
  • Other tips and tools to help you better manage your condition

What is non-infectious uveitis?

Uveitis is inflammation of the uvea, which includes the iris, choroid, and the ciliary body in the eye. It can also affect other parts of the eye, like the retina, vitreous, and optic nerve. (See eye diagram below.)

When uveitis is caused by bacteria, fungi or a virus in the eye, it is considered infectious uveitis. Uveitis caused by something other than infection is considered non-infectious uveitis.

Parts of the eye

Retina Sclera Choroid Optic nerve
Vitreous Cornea Lens Iris Ciliary body

Primary sites of eye inflammation for intermediate, posterior, and panuveitis Enlarge to view

  • Picture of parts of the eye affected by intermediate uveitis symptoms
  • Picture of parts of the eye affected by posterior uveitis symptoms
  • Picture of parts of the eye affected by panuveitis symptoms

Red indicates the affected portion of the eye.

  • Intermediate Uveitis

    Inflammation in the middle section of the eye, called the vitreous

  • Posterior Uveitis

    Inflammation in the back of the eye that may include the retina and the choroid

  • Panuveitis

    Inflammation in all portions of the eye—the front (anterior), middle (intermediate), and back (posterior)

Your safety is important to us.
Learn about our Important Safety Information.

ABOUT HUMIRA® (adalimumab)1

What is the most important information I should know about HUMIRA?

You should discuss the potential benefits and risks of HUMIRA with your doctor. HUMIRA is a TNF blocker medicine that can lower the ability of your immune system to fight infections. You should not start taking HUMIRA if you have any kind of infection unless your doctor says it is okay.

What should I tell my doctor BEFORE starting HUMIRA?

Tell your doctor about all of your health conditions, including if you:

Also tell your doctor about all the medicines you take. You should not take HUMIRA with ORENCIA® (abatacept), KINERET® (anakinra), REMICADE® (infliximab), ENBREL® (etanercept), CIMZIA® (certolizumab pegol), or SIMPONI® (golimumab). Tell your doctor if you have ever used RITUXAN® (rituximab), IMURAN® (azathioprine), or PURINETHOL® (mercaptopurine, 6-MP).

What should I watch for AFTER starting HUMIRA?

HUMIRA can cause serious side effects, including:

Call your doctor or get medical care right away if you develop any of the above symptoms.

Common side effects of HUMIRA include injection site reactions (redness, rash, swelling, itching, or bruising), upper respiratory infections (sinus infections), headaches, rash, and nausea. These are not all of the possible side effects with HUMIRA. Tell your doctor if you have any side effect that bothers you or that does not go away.

Remember, tell your doctor right away if you have an infection or symptoms of an infection, including:

HUMIRA is given by injection under the skin.

This is the most important information to know about HUMIRA. For more information, talk to your health care provider.




HUMIRA is a prescription medicine used:


Please see the Full Prescribing Information, including the Medication Guide, for HUMIRA.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

If you cannot afford your medication, contact: www.pparx.org or call the toll-free phone number (1-888-4PPA-NOW) for assistance.

Please see accompanying full Prescribing Information, including Patient Instructions for Use in the Medication Guide and discuss it with your doctor.

Legal Notices/Privacy Policy. Copyright 2013, AbbVie Inc., North Chicago, Illinois, U.S.A. If you have any questions about AbbVie’s HUMIRA.com website that have not been answered click here. This website and the information contained herein is intended for use by US residents only, is provided for informational purposes only and is not intended to replace a discussion with a healthcare provider. All decisions regarding patient care must be made with a healthcare provider and consider the unique characteristics of each patient.

Reference: 1. HUMIRA Injection [package insert]. North Chicago, IL: AbbVie Inc.


Information from AbbVie


HUMIRA is a prescription medicine used to treat non-infectious intermediate (middle part of the eye), posterior (back of the eye) and panuveitis (all parts of the eye) in adults.


Serious infections have happened in people taking HUMIRA. These serious infections include tuberculosis (TB) and infections caused by viruses, fungi, or bacteria that have spread throughout the body. Some people have died from these infections. HUMIRA may increase the chance of getting lymphoma, including a rare kind, or other cancers. HUMIRA can cause serious side effects including hepatitis B infection in carriers of the virus, allergic reactions, nervous system problems, blood problems, heart failure, certain immune reactions including a lupus-like syndrome, liver problems, and new or worsening psoriasis.